RhumbLine Advisers’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $11.9K | Sell |
|
|||||
|
2024
Q4 | $213K | Buy |
|
|||||
|
2024
Q3 | $24.8K | Sell |
|
|||||
|
2024
Q2 | $82.2K | Buy |
|
|||||
|
2024
Q1 | $100K | Buy |
|
|||||
|
2023
Q4 | $87.1K | Sell |
|
|||||
|
2023
Q3 | $104K | Buy |
|
|||||
|
2023
Q2 | $134K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $69K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $290K | Buy |
|
|||||
|
2021
Q2 | $251K | Sell |
|
|||||
|
2021
Q1 | $419K | Buy |
|
|||||
|
2020
Q4 | $683K | Buy |
|